Current and Emerging Pharmacotherapy for Fibromyalgia.

Feb 28, 2020

. Fibromyalgia syndrome (FMS) is a pain disorder with an estimated prevalence of 1-5%. It is associated with a variety of somatic and psychological disorders. Its exact pathogenesis is still unclear b...

Impact of fatigue on health-related quality of life and illness perception in a monocentric cohort of patients with systemic lupus erythematosus.

Feb 25, 2020

Fatigue is a very common and debilitating symptom in patients with systemic lupus erythematosus (SLE), even among those with a mild or inactive disease. The objective of this study is to define fatigu...

Effects of a functional training programme in patients with Fibromyalgia: A 9-years prospective longitudinal cohort study.

Feb 25, 2020

There are evidences that physical exercise is an effective instrument for improving physical fitness, health and quality of life and causes beneficial effects on the symptoms of patients with fibromya...

Bioinformatics analysis of gene and microRNA targets for fibromyalgia.

Feb 25, 2020

Fibromyalgia (FM) is the most common chronic pain disease in middle-aged women. Patients may also complain of migraine, irritable bowel syndrome and depression, which seriously affect their work and l...

Activation of Transposable Elements in Immune Cells of Fibromyalgia Patients.

Feb 25, 2020

Advancements in nucleic acid sequencing technology combined with an unprecedented availability of metadata have revealed that 45% of the human genome constituted by transposable elements (TEs) is not ...

Opioid Use in Fibromyalgia Continues Despite Guidelines

Feb 14, 2020

The aim of this cross-sectional study is to determine the prevalence of opioid use in a large sample of fibromyalgia (FM) patients and examine the factors associated with opioid prescription/use despi...